Live delivery outcome after tubal sterilization reversal A population based study

Within the first 5 years after sterilization reversal, at least 50% of women sterilized before the age of 40 years successfully deliver a child, but the delivery rate halves after the age of 40 years.

Like Comment


Eva Malacova, Ph.D., Anna Kemp-Casey, Ph.D., Alexandra Bremner, Ph.D., Roger Hart, M.D., C.R.E.I., Louise Maree Stewart, Ph.D., David Brian Preen, Ph.D.

Volume 104, Issue 4, Pages 921-926



To determine the cumulative incidence of live delivery in women who underwent reversal of tubal sterilization.


Population-based retrospective cohort study.


Hospitals in Western Australia.


All women aged 20–44 years, with a history of hospital admission for tubal sterilization, who subsequently underwent reversal of sterilization during the period 1985 to 2009 in Western Australia (n = 1,898).


Data regarding reversal of sterilization and prior tubal sterilization were extracted from routinely collected administrative hospital separation records, until commencement of IVF treatment.

Main Outcome Measure(s):

First live-delivery rates.


There were 969 first live deliveries observed during the study period. The overall cumulative live-delivery rate was 20% (95% confidence interval [CI] 18–23) within the first year after reversal, 40% (95% CI 38–42) at 2 years, 51% (95% CI 48–53) at 5 years, and 52% (95% CI 50–55) at 10 years. The 5-year cumulative live-delivery rate was significantly lower in women who were aged 40–44 years (26%) compared with younger women (aged 20–29, 30–34, and 35–39 years) (50%, 56%, and 51%, respectively).


Women undergoing reversal of sterilization before they reach age 40 years have at least a 50% chance of delivering a live baby within the next 5 years. Up to that age, there is no significant difference in live deliveries. The live-delivery rate halves after the age of 40 years.

Read the full text at:

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.